Log In
BCIQ
Print this Print this
 

CM2489

  Manage Alerts
Collapse Summary General Information
Company CalciMedica Inc.
DescriptionCalcium-release activated calcium (CRAC) channel inhibitor
Molecular Target Calcium release-activated calcium channel (CRAC)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPsoriasis
Indication DetailsTreat moderate to severe plaque psoriasis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today